Nanopia TDM Everolimus
We created this page for medical staff.
*Read carefully the package insert before use.
- Liquid reagent, ready to use
- Applicable to various automated analyzers
- *This package insert follows the Pharmaceuticals, Medical devices and Other Therapeutic Products Act of Japan.
Latex Immunoturbidimetric Assay
When a certain amount of anti-everolimus antibody is added to a specimen, the anti-everolimus antibody binds to everolimus until it has reacted with all of the available everolimus in the specimen. Next, everolimus-coated latex are added, which react with the residual anti-everolimus antibody, leading to agglutination. Since the extent of agglutination depends on the concentration of everolimus in the specimen, the everolimus concentration can be determined by measuring the absorbance as an indicator of agglutination.
|Nanopia TDM Everolimus||EVER Antibody Solution 1||1×18mL||2-8℃|
|EVER Latex Reagent 2||1×5mL|
|Pretreatment Solution 3||1×5mL|
- *Other package sizes are available. Contact SEKISUI MEDICAL CO., LTD. for details.
|Everolimus Calibrator for Nanopia**||Calibrator A(CAL A)||1×6conc.×3mL||-25℃ to -15℃
(with protection from light)
|Calibrator B(CAL B)|
|Calibrator C(CAL C)|
|Calibrator D(CAL D)|
|Calibrator E(CAL E)|
|Calibrator F(CAL F)|
|Everolimus Control for Nanopia**||1×3conc.×3mL|
- **Not in vitro diagnostic products in Japan.
"Nanopia" is a trademark or registered trademark of SEKISUI MEDICAL CO., LTD. in Japan and/or other countries.
TDM (Therapeutic Drug Monitoring) Product List
We prepared this page for medical staff (doctors, dentists, pharmacists, clinical laboratory technicians, nurses, etc.) in Japan to ensure the correct use of our products. You should be aware that the information provided is not intended for overseas medical staff and the general public.